Spyre Therapeutics, Inc.

Contributing Author

Recent Articles by Spyre Therapeutics, Inc.

Feb-06	Spyre Therapeutics Announces Grants of Inducement Awards SYRE +6.62% GlobeNewswire
Jan-23	Spyre Therapeutics Announces Grants of Inducement Awards SYRE -6.03% GlobeNewswire
Jan-12	Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 SYRE +7.15% GlobeNewswire
Jan-08	Spyre Therapeutics Announces Grants of Inducement Awards SYRE GlobeNewswire
Dec-05	Spyre Therapeutics Announces Grants of Inducement Awards SYRE GlobeNewswire
Nov-07	Spyre Therapeutics Announces Grants of Inducement Awards SYRE GlobeNewswire
Nov-04	Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update SYRE GlobeNewswire
Nov-04	Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody SYRE GlobeNewswire
Oct-29	Spyre Therapeutics to Participate in Upcoming November Investor Conferences SYRE GlobeNewswire
Oct-24	Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025 SYRE GlobeNewswire
Oct-15	Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million SYRE +5.67% GlobeNewswire
Oct-13	Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock SYRE +11.02% GlobeNewswire
Oct-13	Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants SYRE +11.02% SYRE GlobeNewswire
Oct-05	Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025 SYRE GlobeNewswire
Oct-03	Spyre Therapeutics Announces Grants of Inducement Awards SYRE GlobeNewswire
Sep-15	Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases SYRE -5.18% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.